Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Pfizer, Inc.
  6. Company
    PFE   US7170811035

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Pfizer, Inc.
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Number of employees : 78 500 people.
Sales per Business
2020
Oncology10 867.0025.9%
Internal Medicine9 003.0021.5%
Hospital7 961.0019%
Vaccines6 575.0015.7%
Inflammation & Immunology4 567.0010.9%
Rare Disease2 936.007%
USD in Million
Sales per region
20192020Delta
United States23 852.0046.1%21 712.0051.8% -8.97%
Developed Europe8 701.0016.8%7 788.0018.6% -10.49%
Emerging Markets8 075.5015.6%5 857.5214% -27.47%
Japan4 140.008%2 514.486% -39.26%
China4 657.509%2 514.486% -46.01%
Developed Rest of World2 325.004.5%1 521.523.6% -34.56%
USD in Million
Managers
Name Title Age Since
Albert Bourla Chairman, Chief Executive & Operating Officer 58 2020
Susan Silbermann President & General Manager-Pfizer Vaccines - -
Frank D'Amelio Chief Financial Officer & EVP-Global Supply 62 2007
Mikael Dolsten Chief Scientific Officer & Research President 62 2019
Lidia Fonseca Executive VP, Chief Digital & Technology Officer 51 -
Aida Habtezion Chief Medical Officer - -
Rady Johnson Executive VP, Chief Compliance & Risk Officer 59 2013
Suzanne Nora Johnson Independent Director 63 2007
Helen H. Hobbs, Dr. Independent Director 67 2011
Shantanu Narayen Lead Independent Director 56 -
Members of the board
Name Title Age Since
Albert Bourla Chairman, Chief Executive & Operating Officer 58 2020
Suzanne Nora Johnson Independent Director 63 2007
Helen H. Hobbs, Dr. Independent Director 67 2011
Shantanu Narayen Lead Independent Director 56 -
James Smith Independent Director 60 2014
Joseph Echevarria Independent Director 63 2015
Ronald E. Blaylock Independent Director 60 2017
Dan R. Littman, Dr. Independent Director 67 2018
Scott Gottlieb, Dr. Independent Director 47 2019
James R. Quincey Independent Director 55 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,463,866,598 5,610,816,436 59.3% 3,851,000,000 40.7% 59.3%
Shareholders
NameEquities%
The Vanguard Group, Inc. 436,283,399 7.78%
SSgA Funds Management, Inc. 279,803,181 4.99%
Capital Research & Management Co. (World Investors) 241,360,858 4.30%
Wellington Management Co. LLP 220,948,772 3.94%
Capital Research & Management Co. 142,320,700 2.54%
BlackRock Fund Advisors 120,282,008 2.15%
Geode Capital Management LLC 99,593,093 1.78%
Northern Trust Investments, Inc.(Investment Management) 67,839,011 1.21%
Norges Bank Investment Management 60,296,992 1.08%
State Farm Investment Management Corp. 53,568,997 0.96%
Holdings
NameEquities%Valuation
PFIZER LIMITED (500680) 29,243,042 63.9% 1,970,670,177 USD
SPRINGWORKS THERAPEUTICS, INC. (SWTX) 4,583,047 9.33% 307,339,132 USD
ARVINAS, INC. (ARVN) 3,457,815 6.57% 299,377,623 USD
MORPHIC HOLDING, INC. (MORF) 1,265,635 3.47% 72,774,013 USD
BIOATLA, INC. (BCAB) 2,238,090 6.93% 65,419,371 USD
SPERO THERAPEUTICS, INC. (SPRO) 2,362,348 7.35% 41,482,831 USD
4D MOLECULAR THERAPEUTICS, INC. (FDMT) 1,666,658 6.09% 40,049,792 USD
SOSEI GROUP CORPORATION (4565) 1,885,136 2.31% 30,039,831 USD
CORTEXYME, INC. (CRTX) 2,056,377 6.93% 27,144,176 USD
NEXTCURE, INC. (NXTC) 1,970,759 7.14% 16,199,639 USD
Markets and indexes
- International Market
- DJIA / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  PFIZ11B:BZ
- Reuters Code :  
- Datastream Code :  
Company contact information
Pfizer, Inc.
235 Street East 42nd
NY 10017 New York City, New York

Phone : +1 212 573 2323
Fax : +1 212 573 7851
web site : http://www.pfizer.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Pfizer, Inc.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
PFIZER, INC.44.09%304 610
JOHNSON & JOHNSON1.27%419 583
ROCHE HOLDING AG17.62%341 364
NOVO NORDISK A/S64.51%244 010
ELI LILLY AND COMPANY47.55%222 641
ABBVIE INC.8.18%210 113
MERCK & CO., INC.-10.34%185 253
NOVARTIS AG-12.05%179 058
ASTRAZENECA PLC11.84%167 779
BRISTOL-MYERS SQUIBB COMPANY-9.21%125 010
SANOFI6.44%118 698
AMGEN INC.-11.95%114 028
GLAXOSMITHKLINE PLC14.35%101 616
CHUGAI PHARMACEUTICAL CO., LTD.-33.20%53 454
JIANGSU HENGRUI MEDICINE CO., LTD.-47.03%49 171
BAYER AG-8.10%49 077
DAIICHI SANKYO COMPANY, LIMITED-19.48%48 251
TAKEDA PHARMACEUTICAL COMPANY LIMITED-18.24%42 287
ASTELLAS PHARMA INC.11.79%29 201
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY36.49%22 646
CATALENT, INC.17.68%20 965